A new antitumor substance, BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity.

The Journal of Antibiotics
1991.0

Abstract

A new antitumor substance, BE-13793C, which has topoisomerase inhibitory activity was isolated from the culture broth of a strain of actinomycetes. The producing strain, BA13793, isolated from a soil sample collected in Seto, Aichi Prefecture, Japan, has a resemblance to Streptoverticillium mobaraense. The active principle was extracted from the mycelium of strain BA13793 with methanol and purified by Sephadex LH-20 column chromatography. BE-13793C showed strong inhibitory activity against topoisomerases I and II and inhibited the growth of doxorubicin-resistant or vincristine-resistant P388 murine leukemia cell lines, as well as their parent P388 cell line.

Knowledge Graph

Similar Paper

A new antitumor substance, BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity.
The Journal of Antibiotics 1991.0
A new antitumor substance, BE-18591, produced by a streptomycete. I. Fermentation, isolation, physico-chemical and biological properties.
The Journal of Antibiotics 1993.0
A new topoisomerase-II inhibitor, BE-10988, produced by a streptomycete. I. Taxonomy, fermentation, isolation and characterization.
The Journal of Antibiotics 1991.0
A new topoisomerase-II inhibitor, BE-10988, produced by a streptomycete. I. Taxonomy, fermentation, isolation and characterization.
The Journal of Antibiotics 1991.0
A new topoisomerase II inhibitor, BE-22179, produced by a streptomycete. I. Producing strain, fermentation, isolation and biological activity.
The Journal of Antibiotics 1994.0
A New Antitumor Antibiotic, BE-19412A, Produced by a Streptomycete.
The Journal of Antibiotics 1998.0
New Cytotoxic Agents, BE-54238A and B, Produced by a Streptomycete.
The Journal of Antibiotics 2000.0
BE-32030 A, B, C, D and E, New Antitumor Substances Produced by Nocardia sp. A32030.
The Journal of Antibiotics 1997.0
Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. I. Taxonomy of producing organism, fermentation and biological activity.
The Journal of Antibiotics 1990.0
A new secondary metabolite from the fermented mycelia of <i>Streptomyces antibiotic</i> H41-55
Journal of Asian Natural Products Research 2018.0